← Back to patent-cliff list
CAS 107871-16-9
ethyl 2-(5-bromopentyl)-1,3-dithiane-2-carboxylate
Codes: Cilastatin Sodium-003
Application context (from source-drug indications)
Infectious diseaseCilastatin Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Cilastatin Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Ethyl 1,3-dithiane-2-carboxylate→Pentamethylene dibromide→ethyl 2-(5-bromopentyl)-1,3-dithiane-2-carboxylate→Ethyl 7-bromo-2-oxoheptanoate→7-bromo-2-oxoheptanoic acid→(+)-(1S)-2,2-Dimethylcyclopropanecarboxamide→(2Z)-7-Bromo-2-([[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino)hept-2-enoic acid→Plant-derived natural amino-acid L-cysteine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.